Translational challenges of animal models in Chagas disease drug development: a review

by Chatelain E, Konar N
Published 2015-08-01

Monocyte Chemotactic Protein 1 in Plasma from Soluble Leishmania Antigen-Stimulated Whole Blood as a Potential Biomarker of the Cellular Immune Response to Leishmania infantum

by Ana V. Ibarra-Meneses, Carmen Sanchez, Jorge Alvar, Javier Moreno, Eugenia Carrillo
Published 2017-09-01

Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania.

by Susan Wyllie, Adam J Roberts, Suzanne Norval, Stephen Patterson, Bernardo J Foth, Matthew Berriman, Kevin D Read, Alan H Fairlamb
Published 2016-11-01

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole

by Philippe Neau, Heinz Hänel, Valérie Lameyre, Nathalie Strub-Wourgaft, Luc Kuykens
Published 2020-01-01

Reflexões sobre as dimensões da informação e comunicação no contexto do modelo de atenção cuidado centrado no paciente na pesquisa clínica

by Gil, Lucia Maria Ballester
Published 2015

Anti-malarial market and policy surveys in sub-Saharan Africa

by Sevcsik Ann-Marie, Boakye Isaac, Amuasi John, Diap Graciela, Pecoul Bernard
Published 2010-04-01

Direito como identidade, direito de patente e doenças negligenciadas: o caso da dengue

by Moreira, Thais Miranda
Published 2017

Reflexões sobre as dimensões da informação e comunicação no contexto do modelo de atenção cuidado centrado no paciente na pesquisa clínica

by Gil, Lucia Maria Ballester
Published 2015

A Comprehensive Review of Cutaneous Leishmaniasis in Kerman Province, Southeastern Iran- Narrative Review Article

by Iraj Sharifi, Mohammad Reza Aflatoonian, Ali Reza Fekri, Maryam Hakimi Parizi, Abbas Aghaei Afshar, Ahmad Khosravi, Fatemeh Sharifi, Behnaz Aflatoonian, Ali Khamesipour, Yahya Dowlati, Farrokh Modabber, Abolhasan Nadim
Published 2015-03-01

How Clinical Research Can Contribute to Strengthening Health Systems in Low Resource Countries

by Florent Mbo, Wilfried Mutombo, Digas Ngolo, Patrice Kabangu, Olaf Valverde Mordt, Nathalie Strub Wourgaft, Erick Mwamba
Published 2020-03-01

Embilica officinalis L. inhibits the growth and proliferation of Leishmania donovani through the induction of ultrastructural changes, mitochondrial dysfunction, oxidative stress a...

by Rahat Ali, Mohammad Islamuddin, Shams Tabrez, Mohammed Alsaweed, Mohammed A. Alaidarous, Bader Mohammed Alshehri, Saeed Banawas, Abdul Aziz Bin Dukhyil, Abdur Rub
Published 2021-11-01

Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic

by Emilie Alirol, Annette C. Kuesel, Maria Magdalena Guraiib, Vânia de la Fuente-Núñez, Abha Saxena, Melba F. Gomes
Published 2017-06-01

Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countries

by Jennifer Osborn, Teri Roberts, Ethan Guillen, Oscar Bernal, Paul Roddy, Stefano Ongarello, Armand Sprecher, Anne-Laure Page, Isabela Ribeiro, Erwan Piriou, Abiy Tamrat, Roberto de la Tour, V. Bhargavi Rao, Laurence Flevaud, Tomas Jensen, Lachlan McIver, Cassandra Kelly, Sabine Dittrich
Published 2020-02-01

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.

by Ridwanur Rahman, Vishal Goyal, Rashidul Haque, Kazi Jamil, Abul Faiz, Rasheda Samad, Sally Ellis, Manica Balasegaram, Margriet den Boer, Suman Rijal, Nathalie Strub-Wourgaft, Fabiana Alves, Jorge Alvar, Bhawna Sharma
Published 2017-05-01

Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia

by Getachew Alebie, Amha Worku, Siele Yohannes, Befikadu Urga, Asrat Hailu, Dagimawie Tadesse
Published 2019-05-01

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter...

by D. Molina-Morant, M. L. Fernández, P. Bosch-Nicolau, E. Sulleiro, M. Bangher, F. Salvador, A. Sanchez-Montalva, A. L. P. Ribeiro, A. M. B. de Paula, S. Eloi, R. Correa-Oliveira, J. C. Villar, S. Sosa-Estani, I. Molina
Published 2020-04-01

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

by Els Torreele, Bernadette Bourdin Trunz, David Tweats, Marcel Kaiser, Reto Brun, Guy Mazué, Michael A Bray, Bernard Pécoul
Published 2010-12-01

Salvage and de novo synthesis of nucleotides in Trypanosoma brucei and mammalian cells

by Fijolek, Artur
Published 2008

Descoberta de novos quimioterápicos para o tratamento de doença de Chagas

by Felipe Santos Barbosa, Artur
Published 2014

Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol

by María L. Cafferata, María A. Toscani, Fernando Althabe, Jose M. Belizán, Eduardo Bergel, Mabel Berrueta, Edmund V. Capparelli, Álvaro Ciganda, Emmaria Danesi, Eric Dumonteil, Luz Gibbons, Pablo E. Gulayin, Claudia Herrera, Jeremiah D. Momper, Steven Rossi, Jeffrey G. Shaffer, Alejandro G. Schijman, Sergio Sosa-Estani, Candela B. Stella, Karen Klein, Pierre Buekens
Published 2020-08-01